Pawloski James reported grant involving 50,000 derivative units of 374Water Inc. on May 29, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 17, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
—Shares × reported price
Shares traded
50,00010% Secured Convertible Note
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
50,000Direct
Trade date
May 29, 2026Grant
Filed
Nov 17, 2026, 5:43 PM ET172-day reporting delay
Accession
0001654954-26-009951Code A · Transaction 404317
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Mar 11, 2026Grant50,000$50,000.00$2,500,000,000Trade 404314
Nov 2, 2026Grant25,000$25,000.00$625,000,000Trade 404320
May 29, 2026Disposition to issuer50,000——Trade 404316
May 29, 2026Disposition to issuer10,000——Trade 404318
Mar 11, 2026Grant10,000$0.00$0Trade 404315
May 29, 2026Grant16,667——Trade 404319
Nov 2, 2026Grant8,333$0.00$0Trade 404321
8 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
2 warnings
delayed filingThe filing was reported 172 calendar days after the transaction date.
missing priceThe filing did not provide a usable price per share.

SCWO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
SCWO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: The reporting person acquired the Issuer's 10% Secured Convertible Notes (the "Notes") and the related common stock purchase warrants (the "Warrants") from the Issuer in a private placement. The reporting person's participation was approved in advance by the Issuer's Board of Directors, and the acquisition is exempt under Rule 16b-3(d). The Notes are reported by principal amount. F2: The Notes were purchased at 100% of their principal amount. The Warrants were issued together with the Notes for no separate consideration. F3: The Notes bear interest at 10% per annum and are convertible, at the holder's option, into common stock at any time before the close of business on the third scheduled trading day preceding the maturity date, which is three years from the date of issuance. The number of underlying shares is the principal amount divided by the conversion price, rounded to the nearest whole share, and excludes accrued and unpaid interest, which is also convertible at the conversion price. On September 30, 2026, $2,780.82 of deferred interest was added to the principal amount of the Note issued on March 11, 2026; that amount is not included in the principal amount or underlying shares reported above. F4: The Warrants are exercisable for cash only, beginning on the date of issuance and expiring three years thereafter. The number of Warrant shares equals 100% of the shares underlying the related Note, rounded to the nearest whole share. F5: On May 29, 2026, the Issuer amended all outstanding Notes and Warrants issued in the private placement, on the same terms for all holders, to reduce the conversion price of the Notes from $5.00 to $3.00 per share, to reduce the exercise price of the Warrants from $7.50 to $4.50 per share, and to increase the number of shares issuable under each Warrant to maintain 100% coverage of the shares underlying the related Note (for the reporting person, from 10,000 to 16,667 shares). No additional consideration was paid. The amendment was approved by the Issuer's Board of Directors and is reported as the deemed cancellation of the original Note and Warrant and the acquisition of the amended Note and Warrant, exempt under Rule 16b-3(e) and Rule 16b-3(d), respectively